Treatment and follow-up of venous thrombosis in the neonatal intensive care unit: A retrospective study

Keyphrases

• Neonatal Intensive Care Unit 100%
• Venous Thrombosis 100%
• Enoxaparin 63%
• Hospitalization 18%
• Postmenstrual Age 18%
• Optimal Dosing 18%
• Low Molecular Weight Heparin 18%
• At Birth 9%
• Major Morbidity 9%
• Adverse Events 9%
• Medical Records 9%
• Critically Ill 9%
• Neonate 9%
• Tertiary Care 9%
• Premature Infant 9%
• Anticoagulation 9%
• Gestational Age 9%
• Relative Safety 9%
• Target Dose 9%
• Short-term Morbidity 9%
• Anti-factor Xa 9%
• Retrospective Medical Record Review 9%
• Long-term Morbidity 9%
• Critically Ill Neonates 9%
• Care Institutions 9%
• Adverse Affects 9%
• Relative Needs 9%
• Anticoagulation Complications 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Retrospective Study 100%
• Vein Thrombosis 100%
• Enoxaparin 63%
• Prematurity 18%
• Low Molecular Weight Heparin 18%
• Adverse Event 9%
• Blood Clotting Factor 10a 9%